B

    Beyond Air Inc (XAIR)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $3.97
    -0.51 (-11.38%)

    Market Cap: $4.41M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    38%(14/37)
    Avg Surprise
    -21.66%
    Streak
    1 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-2.73
    Range$-2.73 - $-2.73
    1 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate Drift
    90d ago$0.00+100.0%
    60d ago$0.00+100.0%
    30d ago$-8.20-200.4%
    7d ago$-8.20-200.4%
    Current$-2.73
    Revenue Consensus
    $2M
    Range$2M - $2M
    1 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Sep 26EST
    		-$-2.73---
    Jun 26
    		$11.00$-8.60+227.91%Beat+819.0%
    Mar 26
    		$-0.77$-0.45-71.11%Miss-755.6%
    Dec 25
    		$-0.85$-0.54-57.41%Miss+71.7%
    Sep 25
    		$-1.25$-0.26-380.77%Miss+77.7%
    Jun 25
    		$-1.53$-1.32-15.91%Miss+71.7%
    Mar 25
    		$-0.09$-0.15+40.00%Beat+75.0%
    Dec 24
    		$-3.00$-3.20+6.25%Beat+70.0%
    Sep 24
    		$-5.60$-5.68+1.41%Beat+45.1%
    Jun 24
    		$-5.40$-6.35+14.96%Beat+40.0%
    Mar 24
    		$-0.36$-0.48+25.00%Beat+46.3%
    Dec 23
    		$-10.00$-10.80+7.41%Beat-16.3%
    Sep 23
    		$-10.20$-9.16-11.35%Miss-27.5%
    Jun 23
    		$-9.00$-8.10-11.11%Miss-21.6%
    Mar 23
    		$-0.67$-0.47-42.55%Miss+8.2%
    Dec 22
    		$-8.60$-8.20-4.88%Miss-48.3%
    Sep 22
    		$-8.00$-6.60-21.21%Miss-11.1%
    Jun 22
    		$-7.40$-5.93-24.79%Miss-19.4%
    Mar 22
    		$-0.73$-0.27-170.37%Miss-204.2%
    Dec 21
    		$-5.80$-5.20-11.54%Miss+12.1%
    Sep 21
    		$-7.20$-6.00-20.00%Miss-20.0%
    Jun 21
    		$-6.20$-4.28-44.86%Miss+22.5%
    Mar 21
    		$-0.24$-0.31+22.58%Beat+33.3%
    Dec 20
    		$-6.60$-6.25-5.60%Miss+23.3%
    Sep 20
    		$-6.00$-6.80+11.76%Beat+21.1%
    Jun 20
    		$-8.00$-6.25-28.00%Miss+40.3%
    Mar 20
    		$-0.36$-0.38+5.26%Beat-187.8%
    Dec 19
    		$-8.60$-6.80-26.47%Miss-490.9%
    Sep 19
    		$-7.60$-6.00-26.67%Miss+28.3%
    Jun 19
    		$-13.40$-5.60-139.29%Miss-3622.2%
    Mar 19
    		$0.41$0.28+46.43%Beat-85.4%
    Dec 18
    		$2.20N/A+148.89%Beat+139.3%
    Sep 18
    		$-10.60$-3.70-186.49%Miss+55.1%
    Jun 18
    		$-0.36$-0.29-24.14%Miss+96.1%
    Mar 18
    		$2.80$-5.13+154.58%Beat+393.2%
    Dec 17
    		$-5.60$-7.87+28.84%Beat+84.2%
    Sep 17
    		$-23.60$-9.53-147.64%Miss-
    Jun 17
    		$-9.20$-5.40-70.37%Miss-
    Mar 17
    		$-0.95N/AN/ABeat-
    Sep 16
    		$-35.42N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio0.49EV/EBITDA-4.23x
    Price/FCF-0.15xFCF Yield-684.40%
    Profitability
    Profit Margin0.00%Operating Margin-374.00%
    ROE-520.00%ROIC-1400.82%
    Financial Health
    Debt/Equity0.23xInterest Coverage-6.25x
    Current Ratio3.31xQuick Ratio3.12x
    Trading Statistics
    Beta0.15Avg Volume541.77K
    52-Week High$95.6052-Week Low$4.25

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$5.01
    SMA 20$5.45
    SMA 50$6.55
    SMA 200$14.66
    EMA 10$4.98
    EMA 20$5.34
    EMA 50$6.45
    EMA 200$18.82

    MACD

    Line: -0.48Signal: -0.41Hist: -0.07

    ADX

    ADX: 26.6+DI: 14.9-DI: 13.8

    Aroon & PSAR

    Aroon Up20.0
    Aroon Down100.0
    PSAR$8.11

    Bollinger Bands

    Upper Band$6.79
    Lower Band$4.11
    %B Position4906%(Upper)
    Band Width-0.05

    RSI (14-Day)

    Neutral
    34.1

    Momentum Oscillators

    Stoch %K19.2
    Stoch %D24.6
    Williams %R-96.4
    ROC (10d)-30.5%
    Momentum-1.74
    CCI (20d)-177.3
    MFI (14d)14.7

    Volatility Measures

    ATR (14d)$1.27(32.0%)
    StdDev (20d)0.67
    Hist Vol139.2%(High)

    Volume Flow

    VWAP$4.11
    OBV548.1M
    AD Line1856.7B
    CMF (20d)-0.404

    Volume Metrics

    Avg Vol (20d)547.2K
    Vol Ratio15.9x(High)
    VWMA (20d)$4.27

    Pivot Points

    R3$5.20
    R2$4.97
    R1$4.72
    Pivot Point$4.49
    S1$4.24
    S2$4.01
    S3$3.76

    Advanced Oscillators

    TSI-19.85
    Ultimate Osc45.8
    KST-177.05

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$1.77M$1.91M$2.19M$1.82M$1.76M$1.15M$1.07M$798,000$683,000$470,000$391,000$239,000
    Cost of Revenue$1.54M$1.81M$1.89M$2.12M$1.60M$1.18M$1.29M$1.88M$1.02M$983,000$748,000$432,000
    Gross Profit$225,000$94,000$300,000$-298,000$156,000$-32,000$-215,000$-1,084,000$-333,000$-513,000$-357,000$-193,000
    Operating Expenses$6.84M$7.26M$6.90M$7.36M$7.77M$7.14M$10.74M$11.75M$13.25M$12.12M$16.61M$17.34M
    R&D$1.96M$2.28M$2.43M$2.45M$3.09M$3.26M$3.00M$4.58M$6.01M$5.70M$6.84M$7.13M
    SG&A$4.88M$4.99M$4.47M$4.91M$4.69M$3.88M$7.73M$7.16M$7.24M$6.42M$5.01M$10.21M
    Operating Income$-6,612,000$-7,170,000$-6,596,000$-7,661,000$-7,617,000$-7,174,000$-10,952,000$-12,833,000$-13,580,000$-12,634,000$-16,963,000$-17,535,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$1.49M$2.27M$1.09M$639,000$548,000$580,000$549,000$927,000$964,000$921,000$919,000$914,000
    Income Before Tax$-8,154,000$-10,368,000$-7,630,000$-8,257,999$-8,078,000$-8,063,000$-13,333,000$-14,029,000$-13,055,000$-14,556,000$-17,258,000$-17,426,000
    Income Tax Expense$0$1.01M$0$0$-387,000$0$-301,000$-671,000$-854,000$-849,000$-1,038,000$-292,000
    Net Income$-7,935,000$-10,282,000$-7,336,000$-7,940,000$-7,691,000$-8,034,000$-13,032,000$-13,358,000$-12,201,000$-13,707,000$-16,219,999$-16,220,000
    EBITDA$-6,459,000$-12,181,000$-5,650,000$-6,798,999$-6,604,000$-6,544,000$-11,928,000$-12,156,000$-11,261,000$-12,898,000$-15,784,000$-16,004,000
    EBITN/A$-12,643,000$-6,542,000$-7,618,999$-7,530,000$-7,483,000$-12,784,000$-13,102,000$-12,091,000$-13,635,000$-16,339,000$-16,512,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about XAIR

    News

    Beyond Air to sell NeuroNOS stake to Univo for 19.99% equity By Investing.com

    Beyond Air Inc. announced a definitive agreement to sell its entire stake in NeuroNOS Israel Ltd. to Univo Pharmaceutical Industries Ltd. In exchange, Beyond Air will receive Univo ordinary shares representing 19.99% of Univo’s capital, along with warrants for additional shares. The deal also includes potential milestone payments totaling up to $32.5 million related to NeuroNOS's neurological disorder and neuro-oncology programs.

    Investing.com Nigeria•8/25/26•
    Somewhat-Bullish

    Beyond Air to Sell NeuroNOS Stake to UNIVO in Equity, Milestone Deal

    Beyond Air, Inc. (NASDAQ: XAIR) has agreed to sell its controlling stake in NeuroNOS Israel Ltd. to UNIVO Pharmaceutical Industries Ltd. (TASE: UNVO). This transaction allows NeuroNOS to receive dedicated resources and funding, while enabling Beyond Air to concentrate on its core LungFit business. Beyond Air will receive a 19.99% equity stake in UNIVO and potential milestone payments up to $32.5 million, maintaining economic exposure to NeuroNOS programs.

    citybiz•8/25/26•
    Somewhat-Bullish

    Beyond Air to sell NeuroNOS stake to Univo for 19.99% equity

    Beyond Air Inc. announced it will sell its approximately 58% stake in NeuroNOS Israel Ltd. to Univo Pharmaceutical Industries Ltd. In exchange, Beyond Air will receive Univo ordinary shares representing 19.99% of Univo's share capital, along with warrants for additional shares. Beyond Air is also eligible for up to $32.5 million in development and commercial milestone payments.

    Investing.com India•8/25/26•
    Somewhat-Bullish

    Beyond Air Enters Definitive Agreement to Sell Its NeuroNOS Stake to UNIVO Pharmaceutical Industries in Exchange for Equity and Milestone Payments

    Beyond Air (NASDAQ: XAIR) has entered into a definitive agreement to sell its entire stake in NeuroNOS Israel Ltd. to UNIVO Pharmaceutical Industries Ltd. In exchange, Beyond Air will receive ordinary shares representing 19.99% of UNIVO's issued share capital, warrants, and is eligible to receive up to $32.5 million in development and commercial milestone payments. This transaction aims to provide NeuroNOS with dedicated resources to advance its pipeline for neurological disorders while allowing Beyond Air to focus on its LungFit business.

    www.marketscreener.com•8/25/26•
    Somewhat-Bullish

    Beyond Air, Inc. SEC Filing (Aug 25, 2026)

    This article reports on an SEC filing by Beyond Air, Inc. (XAIR), specifically a Notice of Effectiveness for Form S-3. The filing was accepted on August 25, 2026, and became effective on August 24, 2026, at 5:00 P.M. The article also provides recent news and other SEC filings related to Beyond Air, Inc., along with key stock data.

    Stock Titan•8/25/26•
    Neutral

    Frequently Asked Questions About XAIR

    Does XAIR pay dividends?
    Beyond Air Inc (XAIR) does not currently pay a regular dividend.
    What is XAIR's P/E ratio?
    Beyond Air Inc has a price-to-earnings (P/E) ratio of 0.49.
    What is XAIR's market cap?
    Beyond Air Inc (XAIR) has a market capitalization of $4.41M with a current stock price of $3.97.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In